Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

NASDAQ:MBOT - Nasdaq - US59503A2042 - Common Stock - Currency: USD

2.13  -0.18 (-7.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MBOT. MBOT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. MBOT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MBOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MBOT has reported negative net income.
MBOT had a negative operating cash flow in the past year.
MBOT had negative earnings in each of the past 5 years.
MBOT had a negative operating cash flow in each of the past 5 years.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -215.15%, MBOT is not doing good in the industry: 92.55% of the companies in the same industry are doing better.
MBOT has a Return On Equity of -294.25%. This is amonst the worse of the industry: MBOT underperforms 82.45% of its industry peers.
Industry RankSector Rank
ROA -215.15%
ROE -294.25%
ROIC N/A
ROA(3y)-111.49%
ROA(5y)-77.78%
ROE(3y)-165.97%
ROE(5y)-111.73%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K 1.5K

1.3 Margins

MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for MBOT has been increased compared to 1 year ago.
The number of shares outstanding for MBOT has been increased compared to 5 years ago.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -12.44, we must say that MBOT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -12.44, MBOT is not doing good in the industry: 81.91% of the companies in the same industry are doing better.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.44
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.64 indicates that MBOT has no problem at all paying its short term obligations.
MBOT's Current ratio of 3.64 is fine compared to the rest of the industry. MBOT outperforms 66.49% of its industry peers.
A Quick Ratio of 3.64 indicates that MBOT has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.64, MBOT is doing good in the industry, outperforming 72.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.64
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

MBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.28%, which is quite impressive.
EPS 1Y (TTM)42.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 21.01% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.85%
EPS Next 2Y21.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MBOT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

MBOT's earnings are expected to grow with 21.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (2/11/2025, 11:58:57 AM)

2.13

-0.18 (-7.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners8.01%
Inst Owner Change-23.04%
Ins Owners1.47%
Ins Owner Change0%
Market Cap36.06M
Analysts82.86
Price Target9.18 (330.99%)
Short Float %10.8%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.69%
Min EPS beat(2)-15.34%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-15.34%
Max EPS beat(4)33.33%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)8
Avg EPS beat(12)3.96%
EPS beat(16)10
Avg EPS beat(16)2.73%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28.57%
PT rev (3m)28.57%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-20%
EPS NY rev (1m)-7.58%
EPS NY rev (3m)-7.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.47
P/tB 9.47
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0
BVpS0.22
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -215.15%
ROE -294.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.49%
ROA(5y)-77.78%
ROE(3y)-165.97%
ROE(5y)-111.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.89%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.64
Altman-Z -12.44
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)66.21%
Cap/Depr(5y)120.44%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.76%
EPS Next Y26.85%
EPS Next 2Y21.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.15%
OCF growth 3YN/A
OCF growth 5YN/A